EXELIXIS INC's ticker is EXEL and the CUSIP is 30161Q104. A total of 359 filers reported holding EXELIXIS INC in Q1 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $59,428 | -90.8% | 3,705 | -89.6% | 0.00% | -100.0% |
Q2 2021 | $647,000 | +125.4% | 35,500 | +148.3% | 0.00% | +200.0% |
Q4 2020 | $287,000 | -69.7% | 14,300 | -64.1% | 0.00% | -85.7% |
Q2 2020 | $947,000 | -71.4% | 39,887 | -78.7% | 0.01% | -66.7% |
Q3 2019 | $3,308,000 | +258.0% | 187,058 | +332.6% | 0.02% | +200.0% |
Q2 2019 | $924,000 | -90.5% | 43,242 | -91.3% | 0.01% | -82.5% |
Q4 2018 | $9,770,000 | +3518.5% | 496,676 | +3157.5% | 0.04% | +1900.0% |
Q3 2018 | $270,000 | -97.0% | 15,247 | -96.4% | 0.00% | -95.8% |
Q2 2018 | $8,997,000 | +1591.2% | 418,054 | +1639.2% | 0.05% | +1500.0% |
Q1 2018 | $532,000 | -96.9% | 24,037 | -95.8% | 0.00% | -97.8% |
Q4 2017 | $17,424,000 | +1628.6% | 573,165 | +1277.6% | 0.13% | +1388.9% |
Q3 2017 | $1,008,000 | +409.1% | 41,606 | -69.8% | 0.01% | +200.0% |
Q4 2014 | $198,000 | +725.0% | 137,600 | +776.4% | 0.00% | – |
Q3 2014 | $24,000 | -94.7% | 15,700 | -88.2% | 0.00% | -100.0% |
Q2 2014 | $452,000 | – | 133,300 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Meditor Group Ltd | 6,816,300 | $106,879,000 | 71.10% |
Krensavage Asset Management, LLC | 1,821,475 | $28,561,000 | 9.09% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 543,000 | $8,509,000 | 2.73% |
CAPITAL MANAGEMENT CORP /VA | 508,493 | $7,973,000 | 2.25% |
SECTORAL ASSET MANAGEMENT INC | 553,375 | $8,677,000 | 1.71% |
Sargent Investment Group, LLC | 282,860 | $4,413,000 | 1.37% |
Stephens Investment Management Group LLC | 4,073,211 | $63,868,000 | 1.21% |
Boxer Capital, LLC | 1,250,000 | $19,600,000 | 1.10% |
Lingohr Asset Management GmbH | 22,493 | $373,000 | 1.02% |
FARALLON CAPITAL MANAGEMENT LLC | 10,675,844 | $167,397,000 | 0.93% |